Cargando…

Vasculogenic mimicry in carcinogenesis and clinical applications

Distinct from classical tumor angiogenesis, vasculogenic mimicry (VM) provides a blood supply for tumor cells independent of endothelial cells. VM has two distinct types, namely tubular type and patterned matrix type. VM is associated with high tumor grade, tumor progression, invasion, metastasis, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Qingxi, Wang, Jun, Zhao, Wenyuan, Peng, Zhenzi, Liu, Xianyu, Li, Bin, Zhang, Heng, Shan, Bin, Zhang, Chunfang, Duan, Chaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071697/
https://www.ncbi.nlm.nih.gov/pubmed/32169087
http://dx.doi.org/10.1186/s13045-020-00858-6
_version_ 1783506261510193152
author Luo, Qingxi
Wang, Jun
Zhao, Wenyuan
Peng, Zhenzi
Liu, Xianyu
Li, Bin
Zhang, Heng
Shan, Bin
Zhang, Chunfang
Duan, Chaojun
author_facet Luo, Qingxi
Wang, Jun
Zhao, Wenyuan
Peng, Zhenzi
Liu, Xianyu
Li, Bin
Zhang, Heng
Shan, Bin
Zhang, Chunfang
Duan, Chaojun
author_sort Luo, Qingxi
collection PubMed
description Distinct from classical tumor angiogenesis, vasculogenic mimicry (VM) provides a blood supply for tumor cells independent of endothelial cells. VM has two distinct types, namely tubular type and patterned matrix type. VM is associated with high tumor grade, tumor progression, invasion, metastasis, and poor prognosis in patients with malignant tumors. Herein, we discuss the recent studies on the role of VM in tumor progression and the diverse mechanisms and signaling pathways that regulate VM in tumors. Furthermore, we also summarize the latest findings of non-coding RNAs, such as lncRNAs and miRNAs in VM formation. In addition, we review application of molecular imaging technologies in detection of VM in malignant tumors. Increasing evidence suggests that VM is significantly associated with poor overall survival in patients with malignant tumors and could be a potential therapeutic target.
format Online
Article
Text
id pubmed-7071697
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70716972020-03-18 Vasculogenic mimicry in carcinogenesis and clinical applications Luo, Qingxi Wang, Jun Zhao, Wenyuan Peng, Zhenzi Liu, Xianyu Li, Bin Zhang, Heng Shan, Bin Zhang, Chunfang Duan, Chaojun J Hematol Oncol Review Distinct from classical tumor angiogenesis, vasculogenic mimicry (VM) provides a blood supply for tumor cells independent of endothelial cells. VM has two distinct types, namely tubular type and patterned matrix type. VM is associated with high tumor grade, tumor progression, invasion, metastasis, and poor prognosis in patients with malignant tumors. Herein, we discuss the recent studies on the role of VM in tumor progression and the diverse mechanisms and signaling pathways that regulate VM in tumors. Furthermore, we also summarize the latest findings of non-coding RNAs, such as lncRNAs and miRNAs in VM formation. In addition, we review application of molecular imaging technologies in detection of VM in malignant tumors. Increasing evidence suggests that VM is significantly associated with poor overall survival in patients with malignant tumors and could be a potential therapeutic target. BioMed Central 2020-03-14 /pmc/articles/PMC7071697/ /pubmed/32169087 http://dx.doi.org/10.1186/s13045-020-00858-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Luo, Qingxi
Wang, Jun
Zhao, Wenyuan
Peng, Zhenzi
Liu, Xianyu
Li, Bin
Zhang, Heng
Shan, Bin
Zhang, Chunfang
Duan, Chaojun
Vasculogenic mimicry in carcinogenesis and clinical applications
title Vasculogenic mimicry in carcinogenesis and clinical applications
title_full Vasculogenic mimicry in carcinogenesis and clinical applications
title_fullStr Vasculogenic mimicry in carcinogenesis and clinical applications
title_full_unstemmed Vasculogenic mimicry in carcinogenesis and clinical applications
title_short Vasculogenic mimicry in carcinogenesis and clinical applications
title_sort vasculogenic mimicry in carcinogenesis and clinical applications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071697/
https://www.ncbi.nlm.nih.gov/pubmed/32169087
http://dx.doi.org/10.1186/s13045-020-00858-6
work_keys_str_mv AT luoqingxi vasculogenicmimicryincarcinogenesisandclinicalapplications
AT wangjun vasculogenicmimicryincarcinogenesisandclinicalapplications
AT zhaowenyuan vasculogenicmimicryincarcinogenesisandclinicalapplications
AT pengzhenzi vasculogenicmimicryincarcinogenesisandclinicalapplications
AT liuxianyu vasculogenicmimicryincarcinogenesisandclinicalapplications
AT libin vasculogenicmimicryincarcinogenesisandclinicalapplications
AT zhangheng vasculogenicmimicryincarcinogenesisandclinicalapplications
AT shanbin vasculogenicmimicryincarcinogenesisandclinicalapplications
AT zhangchunfang vasculogenicmimicryincarcinogenesisandclinicalapplications
AT duanchaojun vasculogenicmimicryincarcinogenesisandclinicalapplications